Study of market for generic drugs; effect of pricing on insurance premiums; report to Legislative Assembly
Or. Rev. Stat. § 646A.697
in effect646A.697. Study of market for generic drugs; effect of pricing on insurance premiums; report to Legislative Assembly
(1) As used in this section, “generic drug” means:
(a) A retail drug that is marketed or distributed in accordance with an abbreviated new drug application approved under 21 U.S.C. 355(j);
(b) An authorized generic as defined by 42 C.F.R. 447.502; or
(c) A drug that entered the market before 1962 that was not originally marketed under a new drug application.
(2) The status of the generic drug market includes but is not limited to:
(a) The prices of generic drugs on a year-to-year basis;
(b) The degree to which generic drug prices affect insurance premiums;
(c) Annual changes in health insurance cost-sharing for generic drugs;
(d) The potential for and history of generic drug shortages; and
(e) The degree to which generic drug prices affect annual spending in the state medical assistance program.
2021 c.598 §6; 2025 c.166 §4
Source: Oregon Legislature (oregonlegislature.gov)URL: https://www.oregonlegislature.gov/bills_laws/ors/ors646a.html#646A.697Fetched: 10/20/2026
